Fortune #45

Theranos attracted investors and media with a promise to run many blood tests from a tiny sample. Erika Cheung and Tyler Shultz joined its laboratory while still young. They did not begin with a plan to bring down a famous company. They began noticing that quality-control results and the machines' actual performance did not match the public picture.

Cheung documented problems and tried internal channels. Shultz raised concerns with executives and with his grandfather, George Shultz, who sat on the board. When assurances from powerful people did not answer the data, both kept patient safety and test results at the center. They contacted regulators and provided information to a journalist despite legal pressure and risks to their careers.

The important distinction is that a confident claim was not rejected merely because the speaker seemed untrustworthy. It was compared with the evidence appropriate to the claim. If a company says a medical device is accurate, the relevant proof is repeatable performance and laboratory standards—not prestige, investment, or confidence on a stage. Verification is responsibility, not cynicism.

When health, money, time, or trust depends on an assurance, first write what evidence should exist. Then find the original source, conditions, limits, and real outcomes. If an ordinary question is answered by pressure to believe quickly or by making you feel guilty, slow down. Strong trust is not frightened by questions. Evidence helps both sides stand in the same reality.